Suppr超能文献

食管鳞状细胞癌放化疗后主要肿瘤组织学效应与淋巴结状态的相关性。

Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus.

作者信息

Yano Masahiko, Yasuda Takushi, Miyata Hiroshi, Fujiwara Yoshiyuki, Takiguchi Shuji, Monden Morito

机构信息

Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

出版信息

J Surg Oncol. 2005 Mar 15;89(4):244-50; discussion 250. doi: 10.1002/jso.20209.

Abstract

BACKGROUND AND OBJECTIVES

Although the histological effectiveness of preoperative chemoradiotherapy against the main tumor is reported to be the strongest prognostic factor for patients with esophageal cancer, it remains unknown whether such chemoradiotherapy is equally effective against metastatic lymph nodes.

METHODS

We studied 103 consecutive patients with esophageal cancer, who were given preoperative chemoradiotherapy followed by surgery. The histological effectiveness against the main tumor of the chemoradiotherapy was correlated with lymph mode metastasis and other clinico-pathological factors.

RESULTS

The histological effectiveness against the main tumor was grade 3 in 26 patients, grade 2 in 49 and grade 1 in 28. The number of pathological node-negative patients was 21 (80.8%), 19 (38.8%), and 7 (25.0%) in those having grade 3, 2, and 1 responses of their main tumors, respectively. The average number of pathological metastatic lymph nodes was 0.19, 1.4, and 4.4 in patients with grade 3, 2, and 1 responses, respectively. Endoscopic biopsy after the chemoradiotherapy could not accurately diagnose the pathological complete response (CR) of the main tumors, with a high false negative rate (60.9%).

CONCLUSIONS

The effects of chemoradiotherapy against main tumors significantly correlated with nodal status. Most patients with main tumors of pathological CR are node-negative. Patients with a grade 2 response have at most a few positive nodes. Surgery would be most beneficial for such patients.

摘要

背景与目的

虽然术前放化疗对主肿瘤的组织学疗效被报道为食管癌患者最强的预后因素,但这种放化疗对转移淋巴结是否同样有效仍不清楚。

方法

我们研究了103例连续的食管癌患者,这些患者接受了术前放化疗然后进行手术。放化疗对主肿瘤的组织学疗效与淋巴结转移及其他临床病理因素相关。

结果

放化疗对主肿瘤的组织学疗效为3级的患者有26例,2级的有49例,1级的有28例。主肿瘤反应为3级、2级和1级的患者中,病理淋巴结阴性患者的数量分别为21例(80.8%)、19例(38.8%)和7例(25.0%)。主肿瘤反应为3级、2级和1级的患者,病理转移淋巴结的平均数量分别为0.19、1.4和4.4个。放化疗后的内镜活检不能准确诊断主肿瘤的病理完全缓解(CR),假阴性率很高(60.9%)。

结论

放化疗对主肿瘤的疗效与淋巴结状态显著相关。大多数病理CR的主肿瘤患者淋巴结阴性。反应为2级的患者最多有少数阳性淋巴结。手术对这类患者最有益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验